CD22 and CD72 contribute to the development of scleroderma in a murine model
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 97 (1) , 66-76
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Inducible costimulator ligand regulates bleomycin‐induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathwayArthritis & Rheumatism, 2010
- Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the MouseThe Journal of Immunology, 2009
- Modulation of peripheral B cell tolerance by CD72 in a murine modelArthritis & Rheumatism, 2008
- B-Lymphocyte Depletion Reduces Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse Model for Systemic SclerosisThe American Journal of Pathology, 2006
- CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouseJournal of Clinical Investigation, 2002
- CD22 Is Both a Positive and Negative Regulator of B Lymphocyte Antigen Receptor Signal Transduction: Altered Signaling in CD22-Deficient MiceImmunity, 1996
- Augmented humoral and anaphylactic responses in FcγRII-deficient miceNature, 1996
- Turnover of naive- and memory-phenotype T cells.Journal of Experimental Medicine, 1994
- Simple method of estimating severity of pulmonary fibrosis on a numerical scale.Journal of Clinical Pathology, 1988
- A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.Journal of Histochemistry & Cytochemistry, 1985